Article

A Managed Care Perspective on Scientific Advances in Amyotrophic Lateral Sclerosis

https://www.pharmacytimes.org/on-demand/scientific-advances-in-als

https://www.pharmacytimes.org/on-demand/scientific-advances-in-als

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Efren Flores, MD
Related Content
Microscopic view of non small cell lung cancer cells. Image Credit: © Keopaserth - stock.adobe.com
September 7th 2025

From Amivantamab to Next-Generation Therapies: The Evolving Bispecific Antibody Landscape in NSCLC

Alana Hippensteele, MA
Managed Care Cast Logo
September 7th 2025

AI in Health Care: Balancing Governance, Innovation, and Trust

Maggie L. Shaw Reuben Daniel
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 7th 2025

Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD

Rose McNulty Surbhi Singhal, MD
managed care cast logo
September 7th 2025

Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA

Brooke McCormick Richard A. Brook, MS, MBA
While omalizumab remains the most validated biologic option for CSU unresponsive to antihistamines, the emergence of dupilumab and remibrutinib as effective alternatives signifies a shift in the management of refractory CSU. | Image Credit: StockWorld - stock.adobe.com
September 7th 2025

Expanding Treatment Options for Chronic Spontaneous Urticaria

Kimberly Rath, PharmD
Child with glasses in classroom | Image credit: Lena May - stock.adobe.com
September 7th 2025

5 Things to Know About Eye Care for Children in School

Julia Bonavitacola

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo